KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $4,926,000 | -3.0% | 493,584 | +23.7% | 0.01% | 0.0% |
Q1 2015 | $5,078,000 | +27.8% | 398,911 | +42.1% | 0.01% | +20.0% |
Q4 2014 | $3,973,000 | +9.9% | 280,804 | +6.8% | 0.01% | +11.1% |
Q3 2014 | $3,616,000 | -2.2% | 262,966 | +9.4% | 0.01% | 0.0% |
Q2 2014 | $3,697,000 | -26.9% | 240,361 | -19.0% | 0.01% | -35.7% |
Q1 2014 | $5,058,000 | +79.9% | 296,817 | +36.8% | 0.01% | +55.6% |
Q4 2013 | $2,811,000 | -2.3% | 217,031 | -23.8% | 0.01% | -10.0% |
Q3 2013 | $2,878,000 | +59.9% | 284,901 | +18.2% | 0.01% | +25.0% |
Q2 2013 | $1,800,000 | – | 241,013 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |